Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Cash from Operations (2022 - 2026)

Centessa Pharmaceuticals has reported Cash from Operations over the past 4 years, most recently at 55807000.0 for Q4 2025.

  • Quarterly Cash from Operations fell 30.39% to 55807000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 193817000.0 through Dec 2025, down 36.44% year-over-year, with the annual reading at 193817000.0 for FY2025, 36.44% down from the prior year.
  • Cash from Operations was 55807000.0 for Q4 2025 at Centessa Pharmaceuticals, up from 58312000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 21389000.0 in Q3 2024 and troughed at 59877000.0 in Q2 2022.
  • The 4-year median for Cash from Operations is 43431000.0 (2023), against an average of 43547500.0.
  • The largest YoY upside for Cash from Operations was 44.67% in 2025 against a maximum downside of 172.63% in 2025.
  • A 4-year view of Cash from Operations shows it stood at 51564000.0 in 2022, then surged by 39.78% to 31050000.0 in 2023, then crashed by 37.84% to 42800000.0 in 2024, then tumbled by 30.39% to 55807000.0 in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Cash from Operations are 55807000.0 (Q4 2025), 58312000.0 (Q3 2025), and 22452000.0 (Q2 2025).